» Articles » PMID: 32242897

LINC00511 Exacerbated T-cell Acute Lymphoblastic Leukemia Via MiR-195-5p/LRRK1 Axis

Overview
Journal Biosci Rep
Specialty Cell Biology
Date 2020 Apr 4
PMID 32242897
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

T-cell acute lymphoblastic leukemia (T-ALL) is a malignant disease arising from the abnormal proliferation of T lymphocyte in marrow. Long non-coding RNAs (lncRNAs) are one kind of non-coding RNAs (ncRNAs), which were reported to modulate the initiation or progression of diverse cancers. However, the role of LINC00511 in T-ALL was unknown. To figure out the function and mechanism of LINC00511 in T-ALL, a series of experiments were carried out. Based on the experimental results, we discovered that LINC00511 boosted cell proliferation and invasion, but hindered cell apoptosis in T-ALL cells. Besides, based on bio-informatics tool, miR-195-5p was selected for further exploration. Then, miR-195-5p was validated to bind with LINC00511. Hereafter, LRRK1 was testified to serve as a target gene of miR-195-5p. At last, rescue assays suggested that LRRK1 overexpression restored sh-LINC00511#1-mediated effects on cell proliferation and apoptosis. All in all, LINC00511 exacerbated T-ALL progression via miR-195-5p/LRRK1 axis, implying a potential therapeutic clue for the patients with T-ALL.

Citing Articles

Recent advances on biogenesis, functions and therapeutic potential of long noncoding RNAs in T cell acute lymphoblastic leukemia.

Kaur P, Sharma P, Bhatia P, Singh M Discov Oncol. 2024; 15(1):729.

PMID: 39612075 PMC: 11607202. DOI: 10.1007/s12672-024-01618-5.


The emerging roles of LINC00511 in breast cancer development and therapy.

Zhao L, Biswas S, Li Y, Sooranna S Front Oncol. 2024; 14:1429262.

PMID: 39206156 PMC: 11349568. DOI: 10.3389/fonc.2024.1429262.


MicroRNA based combinatorial therapy against TKIs resistant CML by inactivating the PI3K/Akt/mTOR pathway: a review.

Singh P Med Oncol. 2023; 40(10):300.

PMID: 37713129 DOI: 10.1007/s12032-023-02161-z.


A review on the role of LINC00511 in cancer.

Ghafouri-Fard S, Safarzadeh A, Hussen B, Taheri M, Ayatollahi S Front Genet. 2023; 14:1116445.

PMID: 37124625 PMC: 10140539. DOI: 10.3389/fgene.2023.1116445.


LncRNA-Based Classification of Triple Negative Breast Cancer Revealed Inherent Tumor Heterogeneity and Vulnerabilities.

Vishnubalaji R, Elango R, Alajez N Noncoding RNA. 2022; 8(4).

PMID: 35893227 PMC: 9326727. DOI: 10.3390/ncrna8040044.


References
1.
Tao H, Zhang J, Qin R, Dai C, Shi P, Yang J . LncRNA GAS5 controls cardiac fibroblast activation and fibrosis by targeting miR-21 via PTEN/MMP-2 signaling pathway. Toxicology. 2017; 386:11-18. DOI: 10.1016/j.tox.2017.05.007. View

2.
Schinnerl D, Fortschegger K, Kauer M, Marchante J, Kofler R, den Boer M . The role of the Janus-faced transcription factor PAX5-JAK2 in acute lymphoblastic leukemia. Blood. 2014; 125(8):1282-91. PMC: 4375719. DOI: 10.1182/blood-2014-04-570960. View

3.
Morimoto K, Baba Y, Shinohara H, Kang S, Nojima S, Kimura T . LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activation. Sci Rep. 2016; 6:25738. PMC: 4863158. DOI: 10.1038/srep25738. View

4.
Wang Y, Wu P, Lin R, Rong L, Xue Y, Fang Y . LncRNA NALT interaction with NOTCH1 promoted cell proliferation in pediatric T cell acute lymphoblastic leukemia. Sci Rep. 2015; 5:13749. PMC: 4557127. DOI: 10.1038/srep13749. View

5.
Ling Z, Wang X, Tao T, Zhang L, Guan H, You Z . Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer. J Exp Clin Cancer Res. 2017; 36(1):159. PMC: 5688662. DOI: 10.1186/s13046-017-0629-7. View